Biotime’s HLC-100 Fully Automated HbA1c Analyzer provides a prompt, reliable solution for diabetes diagnosis. It utilizes the high performance liquid chromatography (HPLC) analytical technique, a gold standard that helps detect glycosylated hemoglobin (HbA1c) with superior precision. Its capability to measure HbA1c, HbF, and other hemoglobin fragments enables clinicians to make quick, accurate diagnoses, thus facilitating timely treatment for the patient.
The incubation chamber is an auxiliary device for Biotime’s fluorescence immunoassay analyzer. The reaction temperature and time is critical for test results. The incubation chamber provides an optimized environment as well as automatic timers for test reactions to improve the reliability of test results.
The Biotime FT4Rapid Quantitative Test is intended to quantify the concentration of FT4 in human serum on the Biotime FIA Analyzer (Semi-automatic / Automatic) by fluorescent immunoassay. The test is used as an aid in the detection of hyperthyroidism. -Fluorescence immunoassay -hyperthyroidism For in vitro diagnostic use only. For professional use only.
The Biotime FT3 Rapid Quantitative Test is intended to quantify the concentration of FT3 in human serum on the Biotime FIA Analyzer (Semi-automatic / Automatic) by fluorescent immunoassay. The test is used as an aid in the detection of hyperthyroidism. -Fluorescence immunoassay -hyperthyroidism For in vitro diagnostic use only. For professional use only.
FLI-4000 is an automatic immunoassay analyzer that measures the concentration of targeted analyte in human blood and urine. FLI-4000 is designed for processing / analyzing large volumes of samples and can carry up to 40 tests per hour (depending on the type of item).
FLI-600 is a fluorescent immunoassay system with 6 channels that uses blood and urine to measure the quantitative concentration of targeted analyte. Its automated test process enables to carry out multiple simultaneous tests for six different samples.
NGAL (neutrophil gelatinase-associated lipocalin, lipocalin-2, sidero- calin) is a novel biomarker for diagnosing acute kidney injury (AKI). Under normal conditions NGAL levels are low in urine and plasma Still, they rise sharply from basal levels in response to kidney injury to reach diagnostic levels within a very short time - as much as 24 hours or more before any significant rise in serum creatinine.
BIOT-YG-I is a fluorescence immunoassay system with single channel that measures the quantitative concentration of a targeted analyte in human blood and urine.
IPv6 network supported 
